Kristi Rosa

Associate Editorial Director of OncLive at MJH Life Sciences

old bridge, new jersey, united states

Publications:

ccgtlive.com

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Featured Articles

EVEREST-1 Trial in Solid Tumors Doses First Patient With A2B530

|Articles|June 4, 2023 EVEREST-1 Trial in Solid Tumors Doses First Patient With A2B530 Author(s) Kristi RosaThe autologous CAR T-cell therapy A2B530 is being investigated for solid tumors in the multicenter, first-in-human, phase 1/2 EVEREST-1 study. Adve... See more

cgtlive.com•Kristi Rosa•Dec 3, 2025

Bylined Articles

HARO Queries

Portfolio

Is this you?

Claim your profile to connect with sources, showcase your work, and earn extra income just by writing great stories.

Claim your profile

Social Media

Pitching Guidelines

Keep it short (under 200 words)
Include credentials and links
Use subject lines with query title

Pitching Guidelines

Quick Stats

Followers

561

Articles1

Last Articlea month ago

Stats

Education

Bachelor Of Arts, English, Writing at Georgian Court UniversityGraduated: 2015

Education

Kristi Rosa

Is this you?

Featured Articles

EVEREST-1 Trial in Solid Tumors Doses First Patient With A2B530

Is this you?

Social Media

Education

Connect with journalists.

Connect with journalists.

Social Media

Featured Articles

EVEREST-1 Trial in Solid Tumors Doses First Patient With A2B530

Education